Show simple item record

II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina

Authordc.contributor.authorPollak, Felipe 
Authordc.contributor.authorAraya Quintanilla, Verónica 
Authordc.contributor.authorLanas Montecinos, Alejandra 
Authordc.contributor.authorSapunar, Jorge 
Authordc.contributor.authorCarrasco Naranjo, Fernando 
Authordc.contributor.authorCodner Dujovne, Ethel 
Authordc.contributor.authorDurruty Alfonso, Pilar 
Authordc.contributor.authorLiberman Guendelman, Claudio 
Authordc.contributor.authorLópez Stewart, Gloria 
Authordc.contributor.authorPoniachik Teller, Jaime 
Authordc.contributor.authorSir Petermann, Teresa 
Authordc.contributor.authorSoto, Néstor 
Admission datedc.date.accessioned2015-09-15T14:56:13Z
Available datedc.date.available2015-09-15T14:56:13Z
Publication datedc.date.issued2015
Cita de ítemdc.identifier.citationRevista médica de Chile. Volumen: 143 Número: 5 Páginas: 627-636en_US
Identifierdc.identifier.otherDOI: 10.4067/S0034-98872015000500012
Identifierdc.identifier.urihttp://repositorio.uchile.cl/handle/2250/133640
General notedc.descriptionArtículo de publicación ISIen_US
Abstractdc.description.abstractInsulin resistance is a prevalent condition commonly associated with unhealthy lifestyles. It affects several metabolic pathways, increasing risk of abnormalities at different organ levels. Thus, diverse medical specialties should be involved in its diagnosis and treatment. With the purpose of unifying criteria about this condition, a scientific-based consensus was elaborated. A questionnaire including the most important topics such as cardio-metabolic risk, non-alcoholic fatty liver disease and polycystic ovary syndrome, was designed and sent to national experts. When no agreement among them was achieved, the Delphi methodology was applied. The main conclusions reached are that clinical findings are critical for the diagnosis of insulin resistance, not being necessary blood testing. Acquisition of a healthy lifestyle is the most important therapeutic tool. Insulin-sensitizing drugs should be prescribed to individuals at high risk of disease according to clinically validated outcomes. There are specific recommendations for pregnant women, children, adolescents and older people.en_US
Lenguagedc.language.isoenen_US
Publisherdc.publisherSociedad Médica de Santiagoen_US
Type of licensedc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Keywordsdc.subjectIntra-abdominal faten_US
Keywordsdc.subjectInsulin resistanceen_US
Keywordsdc.subjectLife styleen_US
Keywordsdc.subjectMetforminen_US
Keywordsdc.subjectRisk factorsen_US
Títulodc.titleII Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulinaen_US
Title in another languagedc.title.alternativeSecond Consensus of the Chilean Society of Endocrinology and Diabetes about insulin resistanceen_US
Document typedc.typeArtículo de revistaen_US


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 Chile
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 Chile